Clinical trial registry record

Autologous Platelet-Rich Plasma Cream for Photoaging and Chronological Skin Aging

A registered PHASE1, PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase 1, phase 2 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated December 1, 2014.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT02303496
Last registry update
December 1, 2014
Status
Unknown
Phase
Phase 1, Phase 2
Sponsor
Acibadem University
Enrollment
20
Countries
Turkey (Türkiye)
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1, PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 1, Phase 2
Study design
RANDOMIZED · SINGLE GROUP · TREATMENT · DOUBLE
Evidence population
Human clinical study registration
Participants
20
Population
FEMALE · 35 Years to 65 Years
Duration
2014-12-01 to 2015-05-01
Intervention
Platelet Rich Plasma Cream; Placebo - Sterile Water Cream
Comparator
SW Cream Application - Placebo
Outcomes measured
Global efficacy evaluations and quantitative analyzes. — T4 (105th day); Deep and fine wrinkling, — T0 (basal condition),T1 (7th day), T2 (15th day), T3 (45th day,) T4 (105th day); Number of Participants with Adverse Events and Type of Adverse Effects. — T1 (7th day), T2 (15th day), T3 (45th day,) T…; Smell and texture of cream — T4 (105th day); Changes from baseline and placebo group. — T0 (basal condition),T1 (7th day), T2 (15th day), T3 (45th day,) T4 (105th d…; Amount of pigmentation — T0 (basal condition),T1 (7th day), T2 (15th day), T3 (45th day,) T4 (105th day); Amount of vascularization — T0 (basal condition),T1 (7th day), T2 (15th day), T3 (45th day,) T4 (105th day); Clarity of skin — T0 (basal condition),T1 (7th day), T2 (15th day), T3 (45th day,) T4 (105th day)
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 1, Phase 2A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Skin ageing · 100%Title contains controlled term: skin aging, photoaging. Abstract contains controlled term: skin aging, photoaging. Source terminology contains: photoaging. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 35%. These figures help sort records; they are not medical ratings.

skin aging
Open primary sourceExport JSON